HeimPFE • NYSE
add
Pfizer Inc
25,65 $
Eftir lokun(0,19%)-0,050
25,60 $
Lokað: 22. nóv., 20:00:00 GMT-5 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
25,13 $
Dagbil
25,10 $ - 25,75 $
Árabil
24,48 $ - 31,54 $
Markaðsvirði
145,36 ma. USD
Meðalmagn
45,27 m.
V/H-hlutf.
34,67
A/V-hlutfall
6,55%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 17,70 ma. | 31,20% |
Rekstrarkostnaður | 6,99 ma. | 0,26% |
Nettótekjur | 4,46 ma. | 287,45% |
Hagnaðarhlutfall | 25,22 | 242,89% |
Hagnaður á hvern hlut | 1,06 | 723,53% |
EBITDA | 7,59 ma. | 1.012,88% |
Virkt skatthlutfall | 4,96% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 9,95 ma. | -77,47% |
Heildareignir | 219,48 ma. | 2,07% |
Heildarskuldir | 126,92 ma. | 7,72% |
Eigið fé alls | 92,56 ma. | — |
Útistandandi hlutabréf | 5,67 ma. | — |
Eiginfjárgengi | 1,54 | — |
Arðsemi eigna | 6,70% | — |
Ávöxtun eigin fjár | 9,17% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 4,46 ma. | 287,45% |
Handbært fé frá rekstri | 6,71 ma. | 94,27% |
Reiðufé frá fjárfestingum | -2,06 ma. | -331,64% |
Reiðufé frá fjármögnun | -4,64 ma. | -22,68% |
Breyting á handbæru fé | 29,00 m. | -94,58% |
Frjálst peningaflæði | 3,35 ma. | 174,32% |
Um
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine, apixaban, a pneumococcal conjugate vaccine, palbociclib, and tafamidis. In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.
The company ranks 38th on the Fortune 500 and 39th on the Forbes Global 2000. Wikipedia
Framkvæmdastjóri
Stofnsett
1849
Höfuðstöðvar
Vefsvæði
Starfsfólk
88.000
